Frank E. Thomas - Apr 1, 2022 Form 4 Insider Report for Orchard Therapeutics plc (ORTX)

Role
Title: President & Chief Operating Officer
Signature
/s/ Frank Thomas
Stock symbol
ORTX
Transactions as of
Apr 1, 2022
Transactions value $
$7,474
Form type
4
Date filed
4/4/2022, 04:15 PM
Previous filing
Jan 7, 2022
Next filing
May 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORTX Ordinary Shares Purchase $7.47K +10K +23.76% $0.75 52.1K Apr 1, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.722 to $0.758. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

Remarks:

Title: President & Chief Operating Officer